VIP is a naturally occurring neuropeptide with remarkably broad physiological effects — from vasodilation and bronchodilation to immune regulation and neuroprotection. Its anti-inflammatory potency has made it a focus in chronic inflammatory condition research.
Research Applications
CIRS/biotoxin illness, pulmonary hypertension, autoimmune modulation, GI motility, neuroprotection, and circadian rhythm regulation.
Dosage Information (Research Use)
Intranasal: 50 mcg per nostril, 1-4 times daily. Subcutaneous and IV protocols also documented. Research use only.
Reconstitution & Handling
Standard BAC water for injection. Nasal spray protocols use preserved saline.
Half-Life & Pharmacokinetics
Approximately 1-2 minutes in plasma. Tissue-level effects persist longer.
Reported Observations in Literature
Vasodilation effects: hypotension, facial flushing, diarrhea. Nasal route reduces systemic effects.
Key Research References
- Gonzalez-Rey E, et al. “Vasoactive intestinal peptide: a first-class immune regulator.” Ann N Y Acad Sci. 2007